Tentative Approval for New Insulin Glargine

(MedPage Today) -- The FDA has tentatively approved Eli Lilly's "biosimilar" insulin glargine (Basaglar), but it won't be on the market until the company resolves patent litigation with Sanofi.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news